Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Alder amends IPO

    Alder Biopharmaceuticals Inc., Bothell, Wash. Business: Antibodies, Autoimmune, Cancer Date announced: 4/25/14 Type: IPO To be raised: Up to $107.3 million Shares: 7.2 million Price: $13-$15 Underwriters: Credit Suisse;…

    Published on 4/28/2014
  • Aldeyra Therapeutics amends IPO

    Aldeyra Therapeutics Inc., Burlington, Mass. Business: Autoimmune, Ophthalmic Date announced: 4/25/14 Type: IPO To be raised: Up to $14.4 million Shares: 1.2 million Price: $10-$12 Underwriter: Aegis Capital …

    Published on 4/28/2014
  • Ariosa Diagnostics amends IPO

    Ariosa Diagnostics Inc., San Jose, Calif. Business: Diagnostic Date announced: 4/24/14 Type: IPO To be raised: Up to $63 million Shares: 3.5 million Price: $16-$18 Underwriters: JPMorgan; Citigroup; Leerink Partners; …

    Published on 4/28/2014
  • Radius Health amends IPO

    Radius Health Inc., Cambridge, Mass. Business: Musculoskeletal Date announced: 4/25/14 Type: IPO To be raised: Up to $80 million Shares: 5 million Price: $14-$16 Underwriters: Jefferies; Cowen; Canaccord; Cantor …

    Published on 4/28/2014
  • Arch Venture Partners financial update

    Arch Venture Partners, Chicago, Ill. Business: Finance Date announced: 4/24/14 Arch Venture Partners is looking to raise $250 million for Arch Venture Fund VIII LP, according to an SEC filing. The firm, which could not …

    Published on 4/28/2014
  • AthernoNova financial update

    AtheroNova Inc. (OTCBB: AHROD), Irvine, Calif. Business: Cardiovascular Date announced: 4/22/14 AtheroNova implemented a 1-for-10 reverse stock split and began trading under the ticker "AHROD." Following the split, …

    Published on 4/28/2014
  • BioSciKin financial update

    BioSciKin, Nanking, China Business: Finance Date announced: 4/22/14 BioSciKin, an incubator for medical products, is targeting RMB1 billion ($160.4 million) for its first fund. The fund will invest in medicines …

    Published on 4/28/2014
  • Celgene financial update

    Celgene Corp. (NASDAQ: CELG), Summit, N.J. Business: Biopharmaceuticals Date announced: 4/24/14 Celgene repurchased 10.7 million shares for about $1.6 billion during 1Q14. Celgene has about $407 million remaining under …

    Published on 4/28/2014
  • Elite financial update

    Elite Pharmaceuticals Inc. (OTCBB:ELTP), Northvale, N.J. Business: Drug delivery Date announced: 4/14/14 Elite Pharmaceuticals entered into a three-year stock purchase agreement for up to $40 million with Lincoln Park …

    Published on 4/28/2014
  • Juno Therapeutics financial update

    Juno Therapeutics Inc., Seattle, Wash. Business: Cancer Date announced: 4/24/14 Juno raised $31 million in the final tranche of a series A round, bringing the total raised in the round to $176 million. The company …

    Published on 4/28/2014
  • Knight Therapeutics financial update

    Knight Therapeutics Inc. (TSX-V:GUD), Westmount, Quebec Business: Infectious Date announced: 4/17/14 Knight said it received conditional approval to transfer its listing to the Toronto Stock Exchange from the Toronto …

    Published on 4/28/2014
  • Lorus financial update

    Lorus Therapeutics Inc. (TSX: LOR; Pink:LRUSF), Toronto, Ontario Business: Cancer, Gene/Cell therapy Date announced: 4/22/14 Lorus raised C$3.3 million ($2.9 million) through the sale of 6.5 million shares at C$0.50 to …

    Published on 4/28/2014
  • Neos Therapeutics financial update

    Neos Therapeutics Inc., Grand Prairie, Texas Business: Drug delivery, Neurology Date announced: 4/23/14 Neos raised an additional $2.5 million in a series C round, bringing the total raised to $18 million. Existing …

    Published on 4/28/2014
  • Spherix financial update

    Spherix Inc. (NASDAQ:SPEX), Tysons Corner, Va. Business: Endocrine/Metabolic Date announced: 4/17/14 Spherix filed a shelf registration covering the sale of up to $30 million of its securities. The shelf registration …

    Published on 4/28/2014
  • Stem Cell Therapeutics financial update

    Stem Cell Therapeutics Corp. (TSX:SSS; OTCQX: SCTPF), Toronto, Ontario Business: Gene/Cell therapy Date announced: 4/21/14 Stem Cell Therapeutics transferred its listing to the Toronto Stock Exchange under the symbol "…

    Published on 4/28/2014
  • ContraFect proposes IPO

    ContraFect Corp., Yonkers, N.Y. Business: Infectious, Antibodies Date announced: 4/18/14 Type: IPO To be raised: Up to $23 million Shares: TBD Price: TBD Underwriter: Maxim Group Note: The company is seeking to list its…

    Published on 4/28/2014
  • Mapi-Pharma amends IPO

    Mapi-Pharma Ltd., Ness Ziona, Israel Business: Drug delivery, Generics Date announced: 4/17/14 Type: IPO To be raised: Up to $42.9 million Shares: 2.9 million Price: $13-$15 Underwriter: Aegis Capital Overallotment: 428…

    Published on 4/21/2014
  • Microlin Bio amends IPO

    Microlin Bio Inc., New York, N.Y. Business: Cancer Date announced: 4/16/14 Type: IPO To be raised: Up to $32.7 million Shares: 2.7 million Price: $10-$12 Underwriters: Brean Capital; Summer Street Overallotment: 409,091…

    Published on 4/21/2014
  • Quotient amends IPO

    Quotient Ltd., Penicuik, U.K. Business: Diagnostic Date announced: 4/14/14 Type: IPO To be raised: Up to $55 million Shares: 5 million Price: $9-$11 Underwriters: UBS; Baird; Cowen Overallotment: 750,000 Note: Quotient …

    Published on 4/21/2014
  • Relypsa financial update

    Relypsa Inc. (NASDAQ:RLYP), Redwood City, Calif. Business: Endocrine/Metabolic Date announced: 4/16/14 Relypsa raised $13.2 million through the sale of 538,775 shares at $24.50 to cover the overallotment from its April …

    Published on 4/21/2014
  • The Column Group financial update

    The Column Group, San Francisco, Calif. Business: Finance Date announced: 4/11/14 Biotech VC firm The Column Group has raised $175.9 million of a planned $250 million for its second fund, according to an SEC filing. The…

    Published on 4/21/2014
  • Angion proposes IPO

    Angion Biomedica Corp., Uniondale, N.Y. Business: Renal, Pulmonary Date announced: 4/14/14 Type: IPO To be raised: Up to $34.5 million Shares: TBD Price: TBD Underwriter: Aegis Capital Note: The company is seeking to …

    Published on 4/21/2014
  • Synta proposes private placement

    Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Lexington, Mass. Business: Cancer, Autoimmune Date announced: 4/14/14 Type: Private placement To be raised: Up to $5 million Shares: 1.3 million Price: $4.01 Shares outstanding…

    Published on 4/21/2014
  • Vyrix Pharmaceutical proposes IPO

    Vyrix Pharmaceutical Inc., Greenwood Village, Colo. Business: Endocrine/Metabolic Date announced: 4/16/14 Type: IPO To be raised: Up to $28.8 million Shares: TBD Price: TBD Underwriters: Aegis Capital; Fordham Financial…

    Published on 4/21/2014
  • Zafgen proposes IPO

    Zafgen Inc., Cambridge, Mass. Business: Endocrine/Metabolic Date announced: 4/18/14 Type: IPO To be raised: Up to $86.3 million Shares: TBD Price: TBD Underwriters: Leerink Partners; Cowen; Canaccord; JMP Securities …

    Published on 4/21/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993